Choice Institutional Equities is bullish on Apollo Pipes has recommended buy rating on the stock with a target price of Rs 350 in its research report dated January 31, 2026.
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively ...
Yamama Cement earns SAR 299M in 9M 2025, SAR 35.9M in Q3 9 M 2025 Yamama Cement H1 2025 profit surges 32% to SAR 263M; Q2 at SAR 121M 6 M 2025 Yamama Cement Q1 2025 profit leaps 24% to SAR 142.1M 3 M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results